ACOU BTA Stock Overview

A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. More details

ACOU BTA fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Revenue is forecast to grow 59.06% per year

Risk Analysis

Earnings have declined by 16.4% per year over past 5 years

Shares are highly illiquid

Shareholders have been substantially diluted in the past year

Does not have a meaningful market cap (SEK74M)

+ 1 more risk

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

AcouSort AB (publ) Competitors

Genetic Analysis

NGM:GEAN

NOK 56.8m

Spago Nanomedical

OM:SPAGO

SEK 63.0m

Alligator Bioscience

OM:ATORX

SEK 67.6m

Dextech Medical

NGM:DEX

SEK 77.3m

Price History & Performance

Summary of share price highs, lows and changes for AcouSort
Historical stock prices
Current Share Price	SEK 3.32
52 Week High	SEK 3.90
52 Week Low	SEK 3.28
Beta	0.65
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-10.27%

Recent updates

Shareholder Returns

	ACOU BTA	SE Biotechs	SE Market
7D	n/a	1.9%	1.2%
1Y	n/a	-0.8%	-4.5%

Return vs Industry: Insufficient data to determine how ACOU BTA performed against the Swedish Biotechs industry.

Return vs Market: Insufficient data to determine how ACOU BTA performed against the Swedish Market.

Price Volatility

Is ACOU BTA's price volatile compared to industry and market?
ACOU BTA volatility
ACOU BTA Average Weekly Movement	n/a
Biotechs Industry Average Movement	9.0%
Market Average Movement	6.8%
10% most volatile stocks in SE Market	14.6%
10% least volatile stocks in SE Market	4.2%

Stable Share Price: ACOU BTA's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: Insufficient data to determine ACOU BTA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2010	17	Torsten Freltoft	www.acousort.com

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy.

AcouSort AB (publ) Fundamentals Summary

How do AcouSort's earnings and revenue compare to its market cap?
ACOU BTA fundamental statistics
Market cap	SEK 74.07m
Earnings (TTM)	-SEK 15.08m
Revenue (TTM)	SEK 10.03m

7.4x

P/S Ratio

-4.9x

P/E Ratio

Is ACOU BTA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACOU BTA income statement (TTM)
Revenue	SEK 10.03m
Cost of Revenue	-SEK 34.00k
Gross Profit	SEK 10.06m
Other Expenses	SEK 25.14m
Earnings	-SEK 15.08m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

May 28, 2025

Earnings per share (EPS)	-0.71
Gross Margin	100.34%
Net Profit Margin	-150.33%
Debt/Equity Ratio	0%

How did ACOU BTA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/06 06:00
End of Day Share Price	2025/05/06 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AcouSort AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
John Westborg	Redeye

AcouSort OM:ACOU BTA Stock Report